Moderna
MRNA
#1830
Rank
C$14.97 B
Marketcap
C$38.33
Share price
8.67%
Change (1 day)
-34.57%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Operating Margin for Moderna (MRNA)

Operating Margin as of December 2025 (TTM): -142.82%

According to Moderna 's latest financial reports and stock price the company's current Operating Margin is -142.82%. At the end of 2024 the company had an Operating Margin of -112.75%.

Operating Margin history for Moderna from 2018 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
2024-112.75%93.19%
2023-58.37%-215.05%
202250.73%-32.28%
202174.90%-127.59%
2020-271.53%-74.69%
2019-1,072.92%241.94%
2018-313.77%116.92%
2017-144.65%-31.74%
2016-211.91%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Regulus Therapeutics
RGLS
-118.00%-17.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
31.06%-121.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-1,576.98% 1,004.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
-16.78%-88.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
29.12%-120.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Arrowhead Pharmaceuticals
ARWR
-17,247.50% 11,976.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
18.78%-113.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-61.01%-57.28%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.